QC
CNMD icon

Quadrature Capital’s CONMED CNMD Stock Holding History

Quadrature Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,153
Closed -$515K – 1085
2024
Q3 		$515K Sell
7,153
-5,586
-44% -$394K 0.01% 518
2024
Q2 		$882K Sell
12,739
-7,533
-37% -$549K 0.01% 488
2024
Q1 		$1.62M Buy
20,272
+7,193
+55% +$641K 0.03% 347
2023
Q4 		$1.43M Buy
13,079
+399
+3% +$41.3K 0.03% 340
2023
Q3 		$1.28M Buy
+12,680
New +$1.46M 0.03% 369
2023
Q1 		– Sell
-3,602
Closed -$319K – 966
2022
Q4 		$319K Sell
3,602
-3,280
-48% -$272K 0.01% 614
2022
Q3 		$552K Buy
+6,882
New +$649K 0.02% 492
2020
Q1 		– Sell
-2,104
Closed -$235K – 535
2019
Q4 		$235K Buy
+2,104
New +$224K 0.01% 428

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Quadrature Capital's CNMD Position: Q4 2024 in Review

Quadrature Capital sold out of CONMED (CNMD) in Q4 2024, closing a stake of 7,153 shares — an estimated $515K sold.

Quadrature Capital first reported a position in CNMD in Q4 2019 and held it in 8 quarters. The position peaked at $1.62M in Q1 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

  • Quadrature Capital reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
  • Quadrature Capital sold 7,153 CONMED shares in Q4 2024, an estimated $515K.
  • Quadrature Capital first reported a position in CONMED in Q4 2019 and held it in 8 quarters.
  • Quadrature Capital's CONMED position peaked at $1.62M in Q1 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Quadrature Capital's 13F filing for Q4 2024, filed 13 Feb 2025.